NIH-funded research NIH-funded research

Creating new compounds to study bacterial sugar metabolism and develop anti-parasitic treatments

Official title: Chemical synthesis to access rare heterocycles and tool compounds to probe bacterial polysaccharide metabolism

Funded at Clemson University · NIH-10841815 · Data updated 2026-11-12

This study is looking at new ways to make special nitrogen-rich compounds that might help fight infections and other health issues, and it could lead to better treatments for patients dealing with bacterial problems or autoimmune diseases.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionClemson University
NIH-funded
Lab location1 site (Clemson, United States)
Project startSeptember 1, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$361,107
NIH project number1R35GM153221-01
Project IDNIH-10841815 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from bacterial infections, autoimmune diseases, or those who may benefit from new anti-parasitic agents.

Less likely to help

Patients with conditions unrelated to bacterial infections or parasitic diseases may not receive any benefit from this research.

What this research studies

This research focuses on developing new synthetic methods to create rare nitrogen-rich compounds that could be used in medicine. By synthesizing a unique compound known as diazacyclobutene (DCB), the researchers aim to explore its potential anti-parasitic properties and other biological activities. Additionally, the study will investigate how gut bacteria metabolize polysaccharides, which could lead to new insights into bacterial infections and autoimmune diseases. Patients may benefit from the findings as they could lead to new treatments for various conditions related to bacterial metabolism and infections.

Why it matters

Potential benefit: If successful, this research could lead to the development of new treatments for bacterial infections and parasitic diseases.

How similar studies have gone: Previous research has shown promise in developing new compounds for treating bacterial infections and parasitic diseases, indicating that this approach could yield significant results.

Where this research is happening

  • Clemson University
    Clemson, United States
    Active

Researchers

  • Principal investigator: Whitehead, Daniel Charles — Clemson University
  • Study coordinator: Whitehead, Daniel Charles

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.